课题基金 / 基金详情

INSULIN HPN & REGULAR PREMIX RATIO 50 & 50 VS PREMIX RATIOS 70 & 30

INSULIN HPN & REGULAR PREMIX RATIO 50 & 50 VS PREMIX RATIOS 70 & 30
胰岛素 HPN
批准号:
6264173
负责人:
MARY KORYTKOWSKI
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MARY KORYTKOWSKI的其他基金

相似基金

相关文献

中文摘要
翻译
本研究将研究每5单位常规胰岛素中含有5单位NPH的预混胰岛素制剂(50/50)和胰岛素制剂(70/30)之间的差异。两个12小时的正常血糖钳夹程序将在健康男性身上进行。受试者将盲法皮下注射0.2单位50/50或70/30的胰岛素制剂。20%的葡萄糖将按滴定的剂量注入,以维持正常血糖。主要的疗效测量将是在注射后的头4小时内维持正常血糖所需的葡萄糖输注率的差异。
英文摘要
This study will investigate differences between a premixed insulin preparation containing 5 units NPH for every 5 units regular insulin (50/50) and a (70/30) insulin preparation. Two 12 hour euglycemic clamp procedures will be performed in healthy men. Subjects will receive 0.2 units subcutaneously of the 50/50 or 70/30 insulin preparation in a blinded manner. Twenty percent dextrose will be infused at a dose titrated to maintain euglycemia. The primary efficacy measure will be the difference in glucose infusion rates required to maintain euglycemia during the first 4 hours after injection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES (BARI 2D)
INSULIN HPN & REGULAR PREMIX RATIO 50 & 50 VS PREMIX RATIOS 70 & 30
SEX HORMONES AS RISK FACTORS FOR HEART DISEASE IN WOMEN WITH NIDDM
HYPERANDROGENISM AS A RISK FACTOR FOR ATHEROGENESIS IN WOMEN WITH NIDDM
海外基金